Growth Metrics

Novartis Ag (NVS) Profit After Tax (QoQ) (2009 - 2023)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2023 346.44%
Mar 31, 2023 -86.74%
Dec 31, 2022 571.36%
Sep 30, 2022 -88.54%
Jun 30, 2022 755.29%
Mar 31, 2022 -87.99%
Dec 31, 2021 671.65%
Sep 30, 2021 -89.27%
Jun 30, 2021 1,064.40%
Mar 31, 2021 -87.28%
Dec 31, 2020 568.87%
Sep 30, 2020 -89.21%
Jun 30, 2020 2,786.60%
Jun 30, 2019 322.65%
Mar 31, 2019 2.89%
Dec 31, 2018 -17.38%
Sep 30, 2018 -92.40%
Jun 30, 2018 1,132.54%
Mar 31, 2018 22.22%
Dec 31, 2017 -12.61%
Sep 30, 2017 -70.34%
Jun 30, 2017 278.39%
Mar 31, 2017 -44.12%
Dec 31, 2016 77.27%
Sep 30, 2016 -5.71%
Jun 30, 2016 202.70%
Mar 31, 2016 -50.53%
Dec 31, 2015 142.86%
Mar 31, 2015 -6.15%
Dec 31, 2014 -1.78%
Sep 30, 2012 -10.63%
Jun 30, 2012 14.23%
Mar 31, 2012 -47.25%
Dec 31, 2011 85.34%
Sep 30, 2011 -3.92%
Jun 30, 2011 -21.32%
Mar 31, 2011 -100.00%
Dec 31, 2010 366,504,754.37%
Sep 30, 2010 -100.00%
Jun 30, 2010 93,995,929,343.69%
Mar 31, 2010 -100.00%
Dec 31, 2009 109,990,430.30%
Sep 30, 2009 -100.00%
Jun 30, 2009 121,215,189,773.42%